{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage",
        "Synthetic replication via swaps",
        "Counterparty risk",
        "Collateralized swap exposure",
        "Daily leverage reset and compounding effects",
        "Opaque payoff structure",
        "High risk rating (7/7)",
        "Short recommended holding period (1 day)",
        "Potential for total loss of investment"
    ],
    "classification": "complex",
    "supporting_data": "The product is a 3x short daily leveraged ETP on Alphabet Inc., using a swap with Natixis as the counterparty, collateralized daily. It employs synthetic replication through total return swaps, which introduces counterparty and collateral risk. The leverage factor is reset daily, causing compounding effects that make returns over longer periods difficult to predict and understand for retail investors. The product is explicitly described as high risk (risk class 7/7), with potential for total loss of capital. The structure is complex due to the embedded leverage, synthetic replication, and the need to understand swap counterparty and collateral risks. The product is not UCITS compliant but an ETP. According to MiFID II rules and ESMA guidance, such features (leverage beyond UCITS limits, synthetic replication, embedded swaps, and complex payoff profiles) classify the product as complex, requiring an appropriateness assessment for retail investors. The productu2019s complexity is further underscored by the mandatory comprehension alert in the KID stating it is 'not simple and may be difficult to understand.' Therefore, it fails the non-complex criteria under Article 57 of the Commission Delegated Regulation and MiFID II provisions. This aligns with regulatory views that leveraged synthetic ETFs or ETPs with embedded derivatives and counterparty risk are complex instruments under MiFID II."
}